Higher risk seen for patients who were male, had multiple comorbidities and more previous emergency department visits
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
AUA: Pandemic Disruptions Impacted One in Four Prostate, Bladder Cancer Patients
Changes, delays, and cancellation of cancer treatment and ancillary care reported
AUA: Kidney Transplants From COVID-19-Infected Donors Are Safe
Recipient outcomes similar to kidneys from noninfected donors
U.S. Airports Digitally Prepare for Summer 2022
The U.S. Transportation Security Administration (TSA) recently announced, for the first time since the COVID-19 pandemic began, that it is prepared for passenger screening activity that may match and occasionally exceed those of 2019.
As of May 13, 2022, TSA data reflects airport checkpoint screening has returned to about 90%.
However, the continued recovery from the low travel volumes may require more patience and planning than was necessary before the pandemic.
Generic Paxlovid Coming to Low- and Middle-Income Countries
The Clinton Health Access Initiative (CHAI) recently announced agreements with leading manufacturers to produce generic Paxlovid available to low- and middle-income countries priced under $25 per treatment course.
Equitable access to effective oral antiviral medications, especially for high-risk populations, will help save lives and limit the impact of future COVID-19 surges.
Persistent Viral Shedding Common in Hospitalized COVID-19 Patients
Persistent viral shedding associated with in-hospital delirium and increased six-month mortality
During Pandemic, Growth of Clinicians With X-Waivers for Buprenorphine Prescribing Slowed
Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine
50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant
Inflammation During COVID-19 Hospitalization Linked to Mortality
Elevated C-reactive protein during hospitalization associated with increased mortality risk after recovery from COVID-19